1. Home
  2. CTKB vs FFC Comparison

CTKB vs FFC Comparison

Compare CTKB & FFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • FFC
  • Stock Information
  • Founded
  • CTKB 1990
  • FFC 1983
  • Country
  • CTKB United States
  • FFC United States
  • Employees
  • CTKB N/A
  • FFC N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • FFC Trusts Except Educational Religious and Charitable
  • Sector
  • CTKB Health Care
  • FFC Finance
  • Exchange
  • CTKB Nasdaq
  • FFC Nasdaq
  • Market Cap
  • CTKB 708.8M
  • FFC 781.4M
  • IPO Year
  • CTKB 2021
  • FFC N/A
  • Fundamental
  • Price
  • CTKB $6.46
  • FFC $15.55
  • Analyst Decision
  • CTKB Strong Buy
  • FFC
  • Analyst Count
  • CTKB 3
  • FFC 0
  • Target Price
  • CTKB $9.17
  • FFC N/A
  • AVG Volume (30 Days)
  • CTKB 892.8K
  • FFC 164.1K
  • Earning Date
  • CTKB 11-05-2024
  • FFC 01-01-0001
  • Dividend Yield
  • CTKB N/A
  • FFC 6.79%
  • EPS Growth
  • CTKB N/A
  • FFC N/A
  • EPS
  • CTKB N/A
  • FFC N/A
  • Revenue
  • CTKB $201,210,000.00
  • FFC N/A
  • Revenue This Year
  • CTKB $7.85
  • FFC N/A
  • Revenue Next Year
  • CTKB $14.82
  • FFC N/A
  • P/E Ratio
  • CTKB N/A
  • FFC N/A
  • Revenue Growth
  • CTKB 9.88
  • FFC N/A
  • 52 Week Low
  • CTKB $4.66
  • FFC $11.90
  • 52 Week High
  • CTKB $9.87
  • FFC $14.96
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 58.79
  • FFC 31.34
  • Support Level
  • CTKB $5.68
  • FFC $15.60
  • Resistance Level
  • CTKB $7.26
  • FFC $15.92
  • Average True Range (ATR)
  • CTKB 0.47
  • FFC 0.20
  • MACD
  • CTKB -0.03
  • FFC -0.03
  • Stochastic Oscillator
  • CTKB 53.94
  • FFC 6.90

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About FFC Flaherty & Crumrine Preferred and Income Securities Fund Incorporated

Flaherty & Crumrine Preferred and Income Securities Fund Incorporated is a diversified, closed-end management investment company. The fund's investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. It invests in a diversified portfolio of preferred securities.

Share on Social Networks: